- US CPI is the key reading during Tuesday session
- WASDE report will show the first look for the 26/27 season
- US CPI is the key reading during Tuesday session
- WASDE report will show the first look for the 26/27 season
Today's macro calendar is primarily focused on inflation, specifically the upcoming data from the United States. Market consensus anticipates a rebound in the headline reading to 3.7% y/y and core inflation to 2.7% y/y. While these levels are not yet extreme, they could mark the highest readings since 2023—or, in the event of an upside surprise, potentially the highest since 2022.
In addition to inflation, we will see the ZEW Index from Germany and the monthly WASDE report. The latter is particularly crucial for agricultural commodity investors, as it will provide the first estimates for the 2026/2027 season. Later in the evening, the API report on US crude oil inventories will be released.
Calendar (All times in BST):
- 10:00 BST – Germany: ZEW Index for May (Forecast: -20.5; Previous: -17.2)
- 13:30 BST – USA: CPI Inflation Report for April:
- Headline Reading (Forecast: 3.7% y/y; Previous: 3.3% y/y)
- Monthly Inflation (Forecast: 0.6% m/m; Previous: 0.9% m/m)
- Core Inflation (Forecast: 2.7% y/y; Previous: 2.6% y/y)
- Monthly Core Inflation (Forecast: 0.4% m/m; Previous: 0.2% m/m)
- 17:00 BST – USA: WASDE report
21:30 BST – USA: API Crude Oil Inventories Report
EURUSD will be the key market to watch during the CPI report release. We can see that the TNOTE points to the much stronger US dollar. Higher CPI reading than expected may deepen the price of the TNOTE even further which may be supportive for the greenback.
Daily Summary: Hot inflation and awaiting for news from Beijing
US OPEN: Higher inflation to cap gains?
🚀 US PPI inflation skyrockets to 6%
Market Wrap: Bulls return to Wall Street (13.05.2026)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
